CELL INTELLIGENCE · 肿瘤细胞治疗研究

rhIL-7-hyFc（一种长效白细胞介素-7）提升 CAR-T 细胞治疗实体瘤的疗效

rhIL-7-hyFc, a long-acting interleukin-7, improves efficacy of CAR-T cell therapy in solid tumors.

本研究为 NT-I7 联合 CAR-T 细胞治疗人类实体瘤提供了依据。

分泌抗 FAP/抗 CD3 分子的间皮素 CAR-T 细胞高效靶向胰腺导管腺癌及其基质

Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma.

CAR-TEAM 细胞能够实现对肿瘤基质的修饰，从而导致 PDAC 肿瘤的清除增加。这种方法为胰腺癌提供了一种有前景的治疗选择。

基于 PBPK-PD 模型表征有或无既往淋巴细胞清除化疗的实体瘤患者中 CAR-T 细胞动力学与疗效

Characterization of CAR-T cellular kinetics and efficacy in solid tumor patients with and without prior lymphodepletion chemotherapy using a PBPK-PD m

CAR-T 细胞治疗非小细胞肺癌的进展

Advances in CAR T Cell Therapy for Non-Small Cell Lung Cancer.